Did a 29 year-old show GlaxoSmithKline that it made a billion dollar mistake?
29 year-old healthcare investor, Vivek Ramaswamy, bought an old Alzheimer's drug that GlaxoSmithKli
1000 year old remedy maybe a solution to a $100 trillion pharmaceutical problem
Researchers at the University of Nottingham’s Centre for Biomolecular Sciences have